Epstein Stacey
Known title: Chief Marketing OfficerCIK: 0001872282
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Freshworks added to S&P SmallCap 600 as shares rise. Freshworks will join the S&P SmallCap 600 index, and the news has moved the stock higher. The inclusion could raise the company's profile among investors. The firm also plans to release its third‑quarter 2026 results on November 3, which may affect trading activity. Recent price action reflects a breakout pattern on the chart.
Transaction History
| VEEV | ▲ Buy | Option Exercise | 891 | $0 | 7/1/2024 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 333 | $60K | 7/1/2024 | View on chart |
| FRSH | ▲ Buy | Grant | 225,903 | $0 | 5/1/2023 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 2,717 | $36K | 5/1/2023 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 3,623 | $48K | 5/1/2023 | View on chart |
| FRSH | ▼ Sell | Other | 21,700 | $0 | 3/31/2023 | View on chart |
| FRSH | ▼ Sell | Open Market | 21,700 | $328K | 3/31/2023 | View on chart |
| FRSH | ▼ Sell | Other | 157,302 | $0 | 3/14/2023 | View on chart |
| FRSH | ▼ Sell | Open Market | 162,187 | $2.3M | 3/14/2023 | View on chart |
| FRSH | ▼ Sell | Other | 36,212 | $0 | 3/10/2023 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 36,212 | $494K | 3/10/2023 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 3,037 | $52K | 2/1/2023 | View on chart |
| FRSH | ▼ Sell | Other | 36,197 | $0 | 12/10/2022 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 36,197 | $533K | 12/10/2022 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 2,717 | $36K | 11/1/2022 | View on chart |
| FRSH | ▼ Sell | Other | 16,300 | $0 | 9/13/2022 | View on chart |
| FRSH | ▼ Sell | Open Market | 16,300 | $237K | 9/13/2022 | View on chart |
| FRSH | ▼ Sell | Other | 36,197 | $0 | 9/10/2022 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 36,197 | $524K | 9/10/2022 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 2,717 | $37K | 8/1/2022 | View on chart |
| FRSH | ▼ Sell | Other | 36,197 | $0 | 6/10/2022 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 36,197 | $447K | 6/10/2022 | View on chart |
| FRSH | ▲ Buy | Grant | 110,070 | $0 | 5/1/2022 | View on chart |
| FRSH | ▼ Sell | Other | 144,804 | $0 | 3/10/2022 | View on chart |
| FRSH | ▼ Sell | Tax Withholding | 144,804 | $2.6M | 3/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Veeva Gains Investor Attention Amid R&D Growth and AI Focus
Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.
Veeva Gains Investor Attention Amid R&D Growth and AI Focus. Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.